Miraculum SA is a cosmetics company involved in developing and marketing face and body care, perfume, depilation, and make-up products for men and women in Poland and internationally. The company also offers shaving products and deodorants.
1924
55
LTM Revenue $12.9M
LTM EBITDA $0.2M
$14.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Miraculum has a last 12-month revenue (LTM) of $12.9M and a last 12-month EBITDA of $0.2M.
In the most recent fiscal year, Miraculum achieved revenue of $11.5M and an EBITDA of $0.1M.
Miraculum expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Miraculum valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $12.9M | XXX | $11.5M | XXX | XXX | XXX |
Gross Profit | $4.4M | XXX | $3.6M | XXX | XXX | XXX |
Gross Margin | 34% | XXX | 32% | XXX | XXX | XXX |
EBITDA | $0.2M | XXX | $0.1M | XXX | XXX | XXX |
EBITDA Margin | 2% | XXX | 1% | XXX | XXX | XXX |
EBIT | -$0.1M | XXX | -$0.2M | XXX | XXX | XXX |
EBIT Margin | -1% | XXX | -2% | XXX | XXX | XXX |
Net Profit | -$0.5M | XXX | -$0.7M | XXX | XXX | XXX |
Net Margin | -4% | XXX | -6% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $4.7M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Miraculum's stock price is PLN 1 (or $0).
Miraculum has current market cap of PLN 42.7M (or $11.3M), and EV of PLN 54.1M (or $14.4M).
See Miraculum trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$14.4M | $11.3M | XXX | XXX | XXX | XXX | $-0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Miraculum has market cap of $11.3M and EV of $14.4M.
Miraculum's trades at 1.2x EV/Revenue multiple, and 125.7x EV/EBITDA.
Equity research analysts estimate Miraculum's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Miraculum has a P/E ratio of -21.0x.
See valuation multiples for Miraculum and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $11.3M | XXX | $11.3M | XXX | XXX | XXX |
EV (current) | $14.4M | XXX | $14.4M | XXX | XXX | XXX |
EV/Revenue | 1.1x | XXX | 1.2x | XXX | XXX | XXX |
EV/EBITDA | 67.7x | XXX | 125.7x | XXX | XXX | XXX |
EV/EBIT | -141.3x | XXX | -59.1x | XXX | XXX | XXX |
EV/Gross Profit | 3.3x | XXX | n/a | XXX | XXX | XXX |
P/E | -21.0x | XXX | -17.3x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -41.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMiraculum's last 12 month revenue growth is 7%
Miraculum's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Miraculum's rule of 40 is 1% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Miraculum's rule of X is 18% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Miraculum and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 7% | XXX | 12% | XXX | XXX | XXX |
EBITDA Margin | 2% | XXX | 1% | XXX | XXX | XXX |
EBITDA Growth | 264% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | 1% | XXX | 8% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 18% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 24% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 34% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Mediterra | XXX | XXX | XXX | XXX | XXX | XXX |
Papoutsanis | XXX | XXX | XXX | XXX | XXX | XXX |
Yalco Constantinoy | XXX | XXX | XXX | XXX | XXX | XXX |
Hindustan Unilever | XXX | XXX | XXX | XXX | XXX | XXX |
Godrej Consumer Products | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Miraculum acquired XXX companies to date.
Last acquisition by Miraculum was XXXXXXXX, XXXXX XXXXX XXXXXX . Miraculum acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Miraculum founded? | Miraculum was founded in 1924. |
Where is Miraculum headquartered? | Miraculum is headquartered in Poland. |
How many employees does Miraculum have? | As of today, Miraculum has 55 employees. |
Is Miraculum publicy listed? | Yes, Miraculum is a public company listed on WAR. |
What is the stock symbol of Miraculum? | Miraculum trades under MIR ticker. |
When did Miraculum go public? | Miraculum went public in 2007. |
Who are competitors of Miraculum? | Similar companies to Miraculum include e.g. Mediterra, Papoutsanis, Yalco Constantinoy, Hindustan Unilever. |
What is the current market cap of Miraculum? | Miraculum's current market cap is $11.3M |
What is the current revenue of Miraculum? | Miraculum's last 12 months revenue is $12.9M. |
What is the current revenue growth of Miraculum? | Miraculum revenue growth (NTM/LTM) is 7%. |
What is the current EV/Revenue multiple of Miraculum? | Current revenue multiple of Miraculum is 1.1x. |
Is Miraculum profitable? | Yes, Miraculum is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Miraculum? | Miraculum's last 12 months EBITDA is $0.2M. |
What is Miraculum's EBITDA margin? | Miraculum's last 12 months EBITDA margin is 2%. |
What is the current EV/EBITDA multiple of Miraculum? | Current EBITDA multiple of Miraculum is 67.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.